reported that METTL3 was downregulated in CML cells, resulting in a decrease in the protein level of nuclear enriched abundant transcript 1 (NEAT1) (70). The gene discussed is METTL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.